Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

490 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Communication and ethical considerations for fertility preservation for patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Mulder RL, Font-Gonzalez A, van Dulmen-den Broeder E, Quinn GP, Ginsberg JP, Loeffen EAH, Hudson MM, Burns KC, van Santen HM, Berger C, Diesch T, Dirksen U, Giwercman A, Gracia C, Hunter SE, Kelvin JF, Klosky JL, Laven JSE, Lockart BA, Neggers SJCMM, Peate M, Phillips B, Reed DR, Tinner EME, Byrne J, Veening M, van de Berg M, Verhaak CM, Anazodo A, Rodriguez-Wallberg K, van den Heuvel-Eibrink MM, Asogwa OA, Brownsdon A, Wallace WH, Green DM, Skinner R, Haupt R, Kenney LB, Levine J, van de Wetering MD, Tissing WJE, Paul NW, Kremer LCM, Inthorn J; PanCareLIFE Consortium. Mulder RL, et al. Among authors: giwercman a. Lancet Oncol. 2021 Feb;22(2):e68-e80. doi: 10.1016/S1470-2045(20)30595-7. Lancet Oncol. 2021. PMID: 33539755 Review.
National guidelines and multilingual age-adapted patient brochures and videos as decision aids for fertility preservation (FP) of children and teenagers with cancer-A multidisciplinary effort to improve children's information and access to FP in Sweden.
Rodriguez-Wallberg KA, Borgström B, Petersen C, Thurin-Kjellberg A, Mörse H, Giwercman A, Jarfelt M; Work Group UNGA (YOUNG) for the Swedish Association of Local Authorities and Regions, SALAR (Sveriges Kommuner och Landsting, SKL). Rodriguez-Wallberg KA, et al. Among authors: giwercman a. Acta Obstet Gynecol Scand. 2019 May;98(5):679-680. doi: 10.1111/aogs.13588. Epub 2019 Mar 13. Acta Obstet Gynecol Scand. 2019. PMID: 30793287 Free article. No abstract available.
Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Mulder RL, Font-Gonzalez A, Hudson MM, van Santen HM, Loeffen EAH, Burns KC, Quinn GP, van Dulmen-den Broeder E, Byrne J, Haupt R, Wallace WH, van den Heuvel-Eibrink MM, Anazodo A, Anderson RA, Barnbrock A, Beck JD, Bos AME, Demeestere I, Denzer C, Di Iorgi N, Hoefgen HR, Kebudi R, Lambalk C, Langer T, Meacham LR, Rodriguez-Wallberg K, Stern C, Stutz-Grunder E, van Dorp W, Veening M, Veldkamp S, van der Meulen E, Constine LS, Kenney LB, van de Wetering MD, Kremer LCM, Levine J, Tissing WJE; PanCareLIFE Consortium. Mulder RL, et al. Lancet Oncol. 2021 Feb;22(2):e45-e56. doi: 10.1016/S1470-2045(20)30594-5. Lancet Oncol. 2021. PMID: 33539753 Review.
Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Mulder RL, Font-Gonzalez A, Green DM, Loeffen EAH, Hudson MM, Loonen J, Yu R, Ginsberg JP, Mitchell RT, Byrne J, Skinner R, Anazodo A, Constine LS, de Vries A, Jahnukainen K, Lorenzo A, Meissner A, Nahata L, Dinkelman-Smit M, Tournaye H, Haupt R, van den Heuvel-Eibrink MM, van Santen HM, van Pelt AMM, Dirksen U, den Hartogh J, van Dulmen-den Broeder E, Wallace WH, Levine J, Tissing WJE, Kremer LCM, Kenney LB, van de Wetering MD; PanCareLIFE Consortium. Mulder RL, et al. Lancet Oncol. 2021 Feb;22(2):e57-e67. doi: 10.1016/S1470-2045(20)30582-9. Lancet Oncol. 2021. PMID: 33539754 Review.
Hypogonadism risk in men treated for childhood cancer.
Romerius P, Ståhl O, Moëll C, Relander T, Cavallin-Ståhl E, Wiebe T, Giwercman YL, Giwercman A. Romerius P, et al. Among authors: giwercman a, giwercman yl. J Clin Endocrinol Metab. 2009 Nov;94(11):4180-6. doi: 10.1210/jc.2009-0337. Epub 2009 Sep 29. J Clin Endocrinol Metab. 2009. PMID: 19789207
Hypogonadism in young men treated for cancer.
Giwercman A, Lundberg Giwercman Y. Giwercman A, et al. Hormones (Athens). 2015 Oct-Dec;14(4):590-7. doi: 10.14310/horm.2002.1650. Hormones (Athens). 2015. PMID: 26859600 Free article. Review.
High risk of hypogonadism in young male cancer survivors.
Isaksson S, Bogefors K, Ståhl O, Eberhard J, Giwercman YL, Leijonhufvud I, Link K, Øra I, Romerius P, Bobjer J, Giwercman A. Isaksson S, et al. Among authors: giwercman a, giwercman yl. Clin Endocrinol (Oxf). 2018 Mar;88(3):432-441. doi: 10.1111/cen.13534. Epub 2018 Jan 10. Clin Endocrinol (Oxf). 2018. PMID: 29245176
490 results